BioCryst Pharmaceuticals, Inc.
Durham
NC
27703
United States
567 articles about BioCryst Pharmaceuticals, Inc.
-
Biocryst Pharmaceuticals To Present At The UBS Global Specialty Pharmaceuticals Conference
4/19/2006
-
Biocryst Pharmaceuticals Announces Presentation Of Forodesine Hydrochloride Data During the 97th Annual Meeting Of The American Association for Cancer Research
4/6/2006
-
Biocryst Pharmaceuticals Initiates Intravenous Peramivir Phase I Clinical Trial
3/9/2006
-
Biocryst Pharmaceuticals To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006
2/10/2006
-
Biocryst Pharmaceuticals Reports Fourth Quarter And Year-End 2005 Financial Results
2/8/2006
-
Biocryst Pharmaceuticals To Release Fourth Quarter And Year-End 2005 Financial Results On Wednesday, February 8, 2006; Conference Call And Webcast To Follow
2/3/2006
-
Biocryst Pharmaceuticals To Present At The 2006 Merrill Lynch Global Pharmaceutical, Biotechnology And Medical Device Conference
2/3/2006
-
Biocryst Pharmaceuticals And Mundipharma International Limited Collaborate On Development Of Fodosine(TM)
2/2/2006
-
Biocryst Pharmaceuticals Gets Fast-Track For Flu Drug; Shares Rise
1/17/2006
-
Biocryst Pharmaceuticals Says FDA OKs Human Test Of Influenza Drug; Sending Shares Up
12/22/2005
-
Biocryst Pharmaceuticals Initiates Intravenous Phase I/II Clinical Trial Of Fodosine(TM) In Patients With B-Cell Acute Lymphoblastic Leukemia
12/22/2005
-
Biocryst Pharmaceuticals Announces Early Termination Of Hart-Scott-Rodino Waiting Period For The Roche License Of BCX-4208
12/22/2005
-
Biocryst Pharmaceuticals And Roche Licensing Deal Wins Early Approval From FTC
12/22/2005
-
Biocryst Pharmaceuticals Completes $30.0 Million Common Stock Offering To Institutional Investors
12/19/2005
-
Biocryst Pharmaceuticals Announces $30.0 Million Common Stock Offering To Institutional Investors
12/15/2005
-
Biocryst Pharmaceuticals Announces Presentation Of Fodosine(TM) Data During The 47th Annual Meeting And Exposition Of The American Society of Hematology
12/12/2005
-
Biocryst Pharmaceuticals To Provide Summary Of Data Presented At The 47th Annual Meeting And Exposition Of The American Society of Hematology
12/7/2005
-
Roche And Biocryst Pharmaceuticals Collaborate On Clinical Compound BCX-4208 For Transplantation And Autoimmune Diseases; Agreement Worth Up To $530 Million
11/30/2005
-
Biocryst Pharmaceuticals To Present At The Lazard Capital Markets Annual Life Sciences Conference
11/28/2005
-
Biocryst Pharmaceuticals Files IND Application For Injectable Peramivir
11/28/2005